A crucial aspect of regenerative treatment and drug research lies in the ability to grow human stem cell populations to sufficient numbers for therapeutic purposes. Traditionally, constrained cell availability posed a significant hindrance to progress in these fields. Consequently, considerable effort has been directed towards optimizing protocols